Tebentafusp may offer a survival benefit for patients with uveal melanoma
- Posted on: May 22 2023
- Leave a response
Tebentafusp appears to promote better overall survival than combined immune checkpoint blockage for certain patients with metastatic uveal melanoma.
Source: AAO
Posted in: Uncategorized